e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Pulmonary circulation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary arterial responses to 5-HT in a novel mouse model of fPAH
I. Morecroft, J. Sheward, A. Harmar, M. R. MacLean (Glasgow, Edinburgh, United Kingdom)
Source:
Annual Congress 2004 - Pulmonary circulation
Session:
Pulmonary circulation
Session type:
Thematic Poster Session
Number:
3464
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Morecroft, J. Sheward, A. Harmar, M. R. MacLean (Glasgow, Edinburgh, United Kingdom). Pulmonary arterial responses to 5-HT in a novel mouse model of fPAH. Eur Respir J 2004; 24: Suppl. 48, 3464
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
A novel murine model of severe pulmonary arterial hypertension
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Expression of the serotonin 1b receptor in experimental pulmonary hypertension
Source: Eur Respir J 2003; 22: 408-412
Year: 2003
Serotonin transporter genes, pulmonary haemodynamics and pulmonary hypertension
Source: Annual Congress 2005 - Scientific year in review
Year: 2005
Anti-contractile and anti-proliferative responses in human pulmonary arterial smooth muscle cells induced by ACT-333679, the active metabolite of selexipag, a non-prostanoid selective prostacyclin receptor agonist
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Overexpression of serotonin receptor 1B (5HT-1B) responsible for overflow induced experimental pulmonary arterial hypertension development
Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation
Year: 2003
Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017
Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Maladaptive Pulmonary vascular responses to chronic intermittent and sustained hypoxia in a rat hypertension model
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Macitentan modulates pulmonary mRNA levels of gremlin 1 in a rat model of pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Shroom expression is attenuated in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 871-880
Year: 2008
Pulmonary arterial hypertension phenotype in VIP knockout mice
Source: Eur Respir J 2006; 28: Suppl. 50, 546s
Year: 2006
Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Effect of zamicastat, a dopamine beta-hydroxylase inhibitor, on the monocrotaline rat model of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
In-vivo lung molecular imaging of choline metabolism in a rat model of pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Short-term mechanisms activated by NGF to induce pulmonary arterial hyperreactivity
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
An investigation of the origins of pulmonary artery lesion cells in pulmonary arterial hypertension rat models
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Two rat models of hemolysis-induced pulmonary hypertension
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept